ALB and lung carcinoma: Advanced Lung Cancer Inflammation Index (ALI) is a new index, which incorporates serum albumin (ALB), BMI and the neutrophil-to-lymphocyte ratio (NLR), are closely linked to the prognosis of cardio-cerebrovascular diseases and was initially used to assess inflammation, nutritional status and prognosis of lung cancer patients (15, 16).